OPRX
ANALYST COVERAGE14 analysts
BUY
+100.0%upside to target
L $7.00
Med $10.50consensus
H $14.00
Buy
1179%
Hold
321%
11 Buy (79%)3 Hold (21%)0 Sell (0%)
Full report →
PRICE
Prev Close
5.21
Open
5.09
Day Range5.09 – 5.30
5.09
5.30
52W Range4.57 – 22.25
4.57
22.25
4% of range
VOLUME & SIZE
Avg Volume
530.1K
FUNDAMENTALS
P/E Ratio
14.6x
Value territory
EPS (TTM)
Div Yield
No dividend
Beta
1.40
Market-like
TECHNICAL
RSI (14)
33
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 91 days
Aug 17
Key MetricsTTM
Market Cap$98.24M
Revenue TTM$107.34M
Net Income TTM$6.84M
Free Cash Flow$14.33M
Gross Margin69.0%
Operating Margin13.6%
Net Margin6.4%
Return on Equity5.5%
Return on Assets4.1%
Debt / Equity0.18
Current Ratio5.37
EPS TTM$0.36

OPRX News

About

OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement.

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Maira AlejandraMedia Relations Manager
Marion Odence-FordChief Legal & Administrative Officer
Sheryl KearneyHuman Resources Manager
Edward StelmakhChief Financial & Strategic Officer
Stephen L. SilvestroChief Executive Officer & Director
Heather FavazzaController
Theresa GrecoChief Commercial Officer
Doug BeschChief Product Officer & Chief Technology Officer
Andrew Jacob D'SilvaChief Business Officer
Brendan MerrellChief Operating Officer